All Psilocybin
- 2 mins to read
The increasing use of psychedelic substances in both clinical and recreational settings has presented a complex clinical challenge regarding the management of acute psychological distress. In a study published in Journal of Psychopharmacology, titled “Trip killers: Addressing a critical knowledge gap in psychedelic research,” O’Mahony and colleagues investigated candidate medications, termed "trip killers," used to attenuate or terminate challenging psychedelic experiences.
- 2 mins to read
Psilocybin is demonstrating significant potential as a therapeutic agent for addressing complex mental health disorders and supporting recovery from brain injury. In a study published in Mini-Reviews in Medicinal Chemistry, titled “Psilocybin: Chemical Foundations and Emerging Therapeutic Potential,” Patil and colleagues investigated the historical, chemical, and pharmacological landscape of psilocybin, focusing on its synthesis and therapeutic application in depression.
Join the Community
Subscribe to receive updates on new research findings, articles and inspired conversations.
We respect your privacy. Unsubscribe at any time.